Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

[1]  L. Walker,et al.  Prolonged evolution of the human B cell response to SARS-CoV-2 infection , 2021, Science Immunology.

[2]  J. Diedrich,et al.  The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein , 2021, Nature Communications.

[3]  Henry A. Utset,et al.  SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike , 2021, mBio.

[4]  M. Nussenzweig,et al.  Evolution of antibody immunity to SARS-CoV-2 , 2021, Nature.

[5]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.

[6]  A. Meola,et al.  Maturation and persistence of the anti-SARS-CoV-2 memory B cell response , 2020, Cell.

[7]  H. Mohammadi,et al.  Critical requirement for BCR, BAFF, and BAFFR in memory B cell survival , 2020, The Journal of experimental medicine.

[8]  M. V. van Zelm,et al.  Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence , 2020, Science Immunology.

[9]  K. Nakayama,et al.  Chromatin Protein PC4 Orchestrates B Cell Differentiation by Collaborating with IKAROS and IRF4. , 2020, Cell reports.

[10]  Karlynn E. Neu,et al.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans , 2020, Science Translational Medicine.

[11]  L. Carter,et al.  Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19 , 2020, Cell.

[12]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to eight months after infection , 2020, bioRxiv.

[13]  A. Pertsemlidis,et al.  Integrative transcriptome and chromatin landscape analysis reveals distinct epigenetic regulations in human memory B cells , 2020, Nature Communications.

[14]  Henry A. Utset,et al.  SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike , 2020, bioRxiv.

[15]  P. Sopp,et al.  Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 , 2020, Nature Immunology.

[16]  Shamus P. Keeler,et al.  Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function , 2020, Nature Immunology.

[17]  L. Carter,et al.  Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 , 2020, medRxiv.

[18]  E. Villa,et al.  The SARS-CoV-2 Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein , 2020, bioRxiv.

[19]  Kira L. Newman,et al.  Distinct Early Serological Signatures Track with SARS-CoV-2 Survival , 2020, Immunity.

[20]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.

[21]  Karlynn E. Neu,et al.  Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses , 2020, Immunity.

[22]  Chenwei Li,et al.  An entropy-based metric for assessing the purity of single cell populations , 2020, Nature Communications.

[23]  J. Dye,et al.  Broad neutralization of SARS-related viruses by human monoclonal antibodies , 2020, Science.

[24]  C. Rice,et al.  Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.

[25]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[26]  Christopher Earl,et al.  Preexisting and de novo humoral immunity to SARS-CoV-2 in humans , 2020, Science.

[27]  Jianqing Xu,et al.  Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies , 2020, Cellular & Molecular Immunology.

[28]  C. Cunningham-Rundles,et al.  A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, Nature Medicine.

[29]  Kaijun Jiang,et al.  SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup , 2020, Current protocols in microbiology.

[30]  J. Zhao,et al.  Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor , 2020, Cellular & Molecular Immunology.

[31]  Zhigang Wu,et al.  Molecular Architecture of the SARS-CoV-2 Virus , 2020, Cell.

[32]  Linqi Zhang,et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.

[33]  A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex , 2020, BMC Immunology.

[34]  Frank Grosveld,et al.  A human monoclonal antibody blocking SARS-CoV-2 infection , 2020, Nature Communications.

[35]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[36]  P. Wilson,et al.  Aging and influenza vaccine-induced immunity. , 2019, Cellular immunology.

[37]  Carole J Henry,et al.  Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination , 2019, Front. Immunol..

[38]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[39]  Kelvin P Lee,et al.  Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle , 2019, Front. Immunol..

[40]  Charles C. Kim,et al.  FCRL5+ Memory B Cells Exhibit Robust Recall Responses , 2019, Cell reports.

[41]  Henry A. Utset,et al.  Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. , 2019, Cell host & microbe.

[42]  I. Wilson,et al.  VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design. , 2019, Current opinion in virology.

[43]  Karlynn E. Neu,et al.  An Efficient Method to Generate Monoclonal Antibodies from Human B Cells. , 2018, Methods in molecular biology.

[44]  H. Eibel,et al.  BAFF and BAFF-Receptor in B Cell Selection and Survival , 2018, Front. Immunol..

[45]  M. Reth,et al.  Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells , 2018, Proceedings of the National Academy of Sciences.

[46]  D. Antonopoulos,et al.  Natural polyreactive IgA antibodies coat the intestinal microbiota , 2017, Science.

[47]  B. Stockinger,et al.  Aryl hydrocarbon receptor is required for optimal B‐cell proliferation , 2016, The EMBO journal.

[48]  M. Jaritz,et al.  Molecular functions of the transcription factors E2A and E2-2 in controlling germinal center B cell and plasma cell development , 2016, The Journal of experimental medicine.

[49]  T. Winkler,et al.  CD83 Modulates B Cell Activation and Germinal Center Responses , 2016, The Journal of Immunology.

[50]  Philippe Kastner,et al.  Ikaros Is a Negative Regulator of B1 Cell Development and Function* , 2016, The Journal of Biological Chemistry.

[51]  Patrick C. Wilson,et al.  Immune history profoundly affects broadly protective B cell responses to influenza , 2015, Science Translational Medicine.

[52]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[53]  T. Kurosaki,et al.  The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program , 2014, Nature Immunology.

[54]  J. Weill,et al.  Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties , 2014, The Journal of experimental medicine.

[55]  D. Gray,et al.  Identification of co‐expressed gene signatures in mouse B1, marginal zone and B2 B‐cell populations , 2014, Immunology.

[56]  C. Nelson,et al.  Oxidative refolding from inclusion bodies. , 2014, Methods in molecular biology.

[57]  G. Damonte,et al.  Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. , 2013, Cell reports.

[58]  H. Kaku,et al.  Human B‐1 cells take the stage , 2013, Annals of the New York Academy of Sciences.

[59]  D. Gray,et al.  Identification of Co-Expressed Gene Signatures in Mouse B 1 , Marginal Zone and B 2 B-cell Populations Running title : Co-expressed gene signatures in B cells , 2013 .

[60]  M. Teitell,et al.  Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. , 2009, Blood.

[61]  G. Ciliberto,et al.  The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells , 2009, The Journal of experimental medicine.

[62]  William Stafford Noble,et al.  Transcription , 2003, Chemistry and Biology of Non‐Canonical Nucleic Acids.

[63]  J. Inazawa,et al.  POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17 , 2008, Oncogene.

[64]  M. Karin,et al.  Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production , 2007, Nature Immunology.

[65]  Andrew Pekosz,et al.  Structure and Intracellular Targeting of the SARS-Coronavirus Orf7a Accessory Protein , 2005, Structure.

[66]  Y. Tu,et al.  Cattoretti and Riccardo Dalla-favera Tracking Cd40 Signaling during Germinal Center Development , 2022 .

[67]  David J Rawlings,et al.  TCL1 Oncogene Expression in B Cell Subsets from Lymphoid Hyperplasia and Distinct Classes of B Cell Lymphoma , 2001, Laboratory Investigation.

[68]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[69]  R. Zinkernagel,et al.  Immunological Memory , 2006 .

[70]  Andreas Radbruch,et al.  Survival of long-lived plasma cells is independent of antigen. , 1998, International immunology.

[71]  G. Nossal,et al.  FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Robert Pepperell,et al.  What is a Human? , 1994, Intell. Tutoring Media.

[73]  D. Pisetsky,et al.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Dr Ferdiye Taner,et al.  The enzyme-linked immunosorbent assay (ELISA). , 1976, Bulletin of the World Health Organization.